Controlled trial of palliative radiotherapy given in two fractions or conventionally fractionated for inoperable non-small-cell lung cancer

N. M. Bleehen, P M Fayers, D J Girling, R.J. Stephens

Research output: Contribution to journalAbstract

Abstract

A total of 374 patients with inoperable non-small cell lung cancer were admitted to the study from March 1985 to February 1988. AU had their main symptoms related to tumour in the chest, even if metastases were present, and had disease too advanced for
radical radiotherapy. They were randomised on admission to receive either high-dose (HD) radiotherapy (17 Gy in two fractions of 8 5 Gy one week apart) or conventional dose
(CD) radiotherapy (30 Gy in 10 fractions in two weeks, or 27 Gy in six fractions in two weeks). The nature and severity of symptoms were recorded monthly by the clinicians.
Nausea, vomiting, dysphagia, level ofphysical activity, mood and overall condition were recorded daily by patients using a diary card. The two regimens achieved similar palliation of symptoms, and both caused a temporary and similar increase in dysphagia. There was no difference between the two series in survival from admission (p = 0-16, log rank test), the median survival periods being HD 28 weeks and CD 31 weeks. The two fraction regimen (HD) is therefore recommended.
Original languageEnglish
Pages (from-to)839P
Number of pages1
JournalThorax
Volume43
Issue number10
DOIs
Publication statusPublished - Oct 1988

Fingerprint

Non-Small Cell Lung Carcinoma
Radiotherapy
Deglutition Disorders
Survival
Nausea
Vomiting
Thorax
Neoplasm Metastasis
Neoplasms

Cite this

Controlled trial of palliative radiotherapy given in two fractions or conventionally fractionated for inoperable non-small-cell lung cancer. / Bleehen, N. M.; Fayers, P M; Girling, D J; Stephens, R.J.

In: Thorax, Vol. 43, No. 10, 10.1988, p. 839P.

Research output: Contribution to journalAbstract

@article{26a30b8f015e4ad3b5d034b9bc62a1ce,
title = "Controlled trial of palliative radiotherapy given in two fractions or conventionally fractionated for inoperable non-small-cell lung cancer",
abstract = "A total of 374 patients with inoperable non-small cell lung cancer were admitted to the study from March 1985 to February 1988. AU had their main symptoms related to tumour in the chest, even if metastases were present, and had disease too advanced forradical radiotherapy. They were randomised on admission to receive either high-dose (HD) radiotherapy (17 Gy in two fractions of 8 5 Gy one week apart) or conventional dose(CD) radiotherapy (30 Gy in 10 fractions in two weeks, or 27 Gy in six fractions in two weeks). The nature and severity of symptoms were recorded monthly by the clinicians.Nausea, vomiting, dysphagia, level ofphysical activity, mood and overall condition were recorded daily by patients using a diary card. The two regimens achieved similar palliation of symptoms, and both caused a temporary and similar increase in dysphagia. There was no difference between the two series in survival from admission (p = 0-16, log rank test), the median survival periods being HD 28 weeks and CD 31 weeks. The two fraction regimen (HD) is therefore recommended.",
author = "Bleehen, {N. M.} and Fayers, {P M} and Girling, {D J} and R.J. Stephens",
year = "1988",
month = "10",
doi = "10.1136/thx.43.10.803P",
language = "English",
volume = "43",
pages = "839P",
journal = "Thorax",
issn = "0040-6376",
publisher = "BMJ Publishing Group Ltd",
number = "10",

}

TY - JOUR

T1 - Controlled trial of palliative radiotherapy given in two fractions or conventionally fractionated for inoperable non-small-cell lung cancer

AU - Bleehen, N. M.

AU - Fayers, P M

AU - Girling, D J

AU - Stephens, R.J.

PY - 1988/10

Y1 - 1988/10

N2 - A total of 374 patients with inoperable non-small cell lung cancer were admitted to the study from March 1985 to February 1988. AU had their main symptoms related to tumour in the chest, even if metastases were present, and had disease too advanced forradical radiotherapy. They were randomised on admission to receive either high-dose (HD) radiotherapy (17 Gy in two fractions of 8 5 Gy one week apart) or conventional dose(CD) radiotherapy (30 Gy in 10 fractions in two weeks, or 27 Gy in six fractions in two weeks). The nature and severity of symptoms were recorded monthly by the clinicians.Nausea, vomiting, dysphagia, level ofphysical activity, mood and overall condition were recorded daily by patients using a diary card. The two regimens achieved similar palliation of symptoms, and both caused a temporary and similar increase in dysphagia. There was no difference between the two series in survival from admission (p = 0-16, log rank test), the median survival periods being HD 28 weeks and CD 31 weeks. The two fraction regimen (HD) is therefore recommended.

AB - A total of 374 patients with inoperable non-small cell lung cancer were admitted to the study from March 1985 to February 1988. AU had their main symptoms related to tumour in the chest, even if metastases were present, and had disease too advanced forradical radiotherapy. They were randomised on admission to receive either high-dose (HD) radiotherapy (17 Gy in two fractions of 8 5 Gy one week apart) or conventional dose(CD) radiotherapy (30 Gy in 10 fractions in two weeks, or 27 Gy in six fractions in two weeks). The nature and severity of symptoms were recorded monthly by the clinicians.Nausea, vomiting, dysphagia, level ofphysical activity, mood and overall condition were recorded daily by patients using a diary card. The two regimens achieved similar palliation of symptoms, and both caused a temporary and similar increase in dysphagia. There was no difference between the two series in survival from admission (p = 0-16, log rank test), the median survival periods being HD 28 weeks and CD 31 weeks. The two fraction regimen (HD) is therefore recommended.

U2 - 10.1136/thx.43.10.803P

DO - 10.1136/thx.43.10.803P

M3 - Abstract

VL - 43

SP - 839P

JO - Thorax

JF - Thorax

SN - 0040-6376

IS - 10

ER -